Literature DB >> 10548116

Quantitative morphologic and functional evaluation of the optic nerve head in chronic open-angle glaucoma.

K U Bartz-Schmidt1, G Thumann, C P Jonescu-Cuypers, G K Krieglstein.   

Abstract

Glaucoma leads to morphologic changes of the optic nerve head and to functional defects. Morphologic changes in the three-dimensional surface structure of the optic nerve head at its entrance site into the globe can be examined by laser scanning tomography. The standard technique for evaluating functional defects in glaucoma is static computerized perimetry. We compared these two techniques to determine which is more sensitive for follow-up of glaucomatous damage of the optic nerve head. If decreased function is presumed to precede imminent cell death, visual field analysis should be the more sensitive method, as cell death results in absolute defects of the visual field. However, the neuronal networks do not necessarily function in this way. In the case of loss of individual elements in the neuronal network, the complex linkages, even at the retinal level, are able to maintain functions and compensate for loss of function, which means that visual field defects would not be prominent. If the damage increases with time and is accompanied by a progressive loss of ganglion cells, however, compensation is eventually no longer possible, and the functional defects then become measurable by visual field analysis. Thus, morphologic absolute changes may be more prominent than visual field defects in the early stages of glaucoma. To evaluate the quantitative relationship between morphometrically measurable defects of the optic nerve head and measurable functional defects, we first examined the visual field with static computerized perimetry and then evaluated the surface structure with a laser scanning tomograph in 90 patients with chronic open-angle glaucoma, 10 patients with ocular hypertension, and 10 patients without any eye disease. Based on the 95th percentile of the standardized rim/disk area ratio, we calculated the relative rim area loss and correlated this with the mean defect in visual field analysis. The scatterplot shows an exponential curve. In the early stages of glaucoma, visual field defects were less prominent than morphologic absolute changes; 40% of the neuroretinal rim area is lost by glaucomatous optic nerve damage before first defects in visual field analysis appear. In late stages of glaucoma, changes in perimetry are more prominent than those observed with biomorphometry. These results show that in the follow-up of patients with early stages of glaucomatous damage, special attention should be given to morphologic absolute changes. In patients with advanced glaucoma, progress of the damage should be observed by repeated functional, rather than morphologic, examinations. It is important to keep in mind, however, that the sensitivity of any method is dependent on technology. One reason why functional tests may not be as sensitive as morphologic examination in observing patients with early stages of glaucoma may simply be that functional tests are not yet sensitive enough to detect early damage.

Entities:  

Mesh:

Year:  1999        PMID: 10548116     DOI: 10.1016/s0039-6257(99)00076-4

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  20 in total

1.  The correlation between optic nerve head topographic measurements, peripapillary nerve fibre layer thickness, and visual field indices in glaucoma.

Authors:  Y-W Lan; D B Henson; A J Kwartz
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

2.  Structural and functional assessment by hemispheric asymmetry testing of the macular region in preperimetric glaucoma.

Authors:  Chiaki Kawaguchi; Yusuke Nakatani; Shinji Ohkubo; Tomomi Higashide; Ichiro Kawaguchi; Kazuhisa Sugiyama
Journal:  Jpn J Ophthalmol       Date:  2013-12-10       Impact factor: 2.447

3.  Evaluation of Visual Field and Imaging Outcomes for Glaucoma Clinical Trials (An American Ophthalomological Society Thesis).

Authors:  David F Garway-Heath; Ana Quartilho; Philip Prah; David P Crabb; Qian Cheng; Haogang Zhu
Journal:  Trans Am Ophthalmol Soc       Date:  2017-08-22

4.  Why Do People (Still) Go Blind from Glaucoma?

Authors:  Remo Susanna; Carlos Gustavo De Moraes; George A Cioffi; Robert Ritch
Journal:  Transl Vis Sci Technol       Date:  2015-03-09       Impact factor: 3.283

5.  Central visual function and inner retinal structure in primary open-angle glaucoma.

Authors:  Li-Juan Xu; Sha-Ling Li; Vance Zemon; Yan-Qian Xie; Yuan-Bo Liang
Journal:  J Zhejiang Univ Sci B       Date:  2020 Apr.       Impact factor: 3.066

6.  Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma.

Authors:  Gadi Wollstein; Joel S Schuman; Lori L Price; Ali Aydin; Paul C Stark; Ellen Hertzmark; Edward Lai; Hiroshi Ishikawa; Cynthia Mattox; James G Fujimoto; Lelia A Paunescu
Journal:  Arch Ophthalmol       Date:  2005-04

Review 7.  'Structure-function relationship' in glaucoma: past thinking and current concepts.

Authors:  Rizwan Malik; William H Swanson; David F Garway-Heath
Journal:  Clin Exp Ophthalmol       Date:  2012-04-12       Impact factor: 4.207

8.  Automatic glaucoma diagnosis through medical imaging informatics.

Authors:  Jiang Liu; Zhuo Zhang; Damon Wing Kee Wong; Yanwu Xu; Fengshou Yin; Jun Cheng; Ngan Meng Tan; Chee Keong Kwoh; Dong Xu; Yih Chung Tham; Tin Aung; Tien Yin Wong
Journal:  J Am Med Inform Assoc       Date:  2013-03-28       Impact factor: 4.497

Review 9.  ASSESSMENT OF CLINICAL AND IMAGISTIC STRUCTURAL PROGRESSION IN GLAUCOMA.

Authors:  Alina Popa Cherecheanu; Raluca Iancu; Ana-Maria Dascalu; Dragos Serban; Ruxandra Pirvulescu
Journal:  Rom J Ophthalmol       Date:  2015 Jul-Sep

10.  [Sensitivity and specificity of flicker perimetry with Pulsar. Comparison with achromatic (white-on-white) perimetry in glaucoma patients].

Authors:  K Göbel; C Erb
Journal:  Ophthalmologe       Date:  2013-02       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.